Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
49.53
+0.63 (1.29%)
At close: Dec 5, 2025, 4:00 PM EST
49.63
+0.10 (0.20%)
After-hours: Dec 5, 2025, 6:36 PM EST
Sanofi Revenue
Sanofi had revenue of 13.17B EUR in the quarter ending September 30, 2025, a decrease of -6.97%. This brings the company's revenue in the last twelve months to 45.93B, down -5.19% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.93B EUR
Revenue Growth
-5.19%
P/S Ratio
2.23
Revenue / Employee
554,200 EUR
Employees
82,878
Market Cap
120.32B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SNY News
- 1 day ago - Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns - Reuters
- 2 days ago - Press Release: Sanofi completes acquisition of Vicebio - GlobeNewsWire
- 2 days ago - LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes - Business Wire
- 2 days ago - Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 days ago - Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 11 days ago - Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe - Benzinga
- 11 days ago - Press Release: Sanofi and Regeneron's Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria - GlobeNewsWire
- 16 days ago - Bristol Myers, Sanofi sued by Texas over Plavix - Reuters